American Journal of Health-System Pharmacy : AJHP This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Approaches to medication history taking in different hospital settings: A scoping review
CONCLUSION: Most approaches focused on pharmacy staff, which are associated with considerable cost and resources. Therefore, IT-based approaches and patient engagement should be investigated as cost-effective alternatives and tested for superiority in the same setting. Reporting guidelines and standardized methodology are needed to improve the comparability of such studies.PMID:38660785 | DOI:10.1093/ajhp/zxae112 (Source: American Journal of Health-System Pharmacy : AJHP)
Source: American Journal of Health-System Pharmacy : AJHP - April 25, 2024 Category: Drugs & Pharmacology Authors: Theresa Terstegen Christina Niestroj Julia Stangl Camilo Scherkl Benedict Morath Walter E Haefeli Hanna M Seidling Source Type: research

National trends in prescription drug expenditures and projections for 2024
CONCLUSION: For 2024, we expect overall prescription drug spending to rise by 10.0% to 12.0%, whereas in clinics and hospitals we anticipate an 11.0% to 13.0% increase and a 0% to 2.0% increase, respectively, compared to 2023. These national estimates of future pharmaceutical expenditure growth may not be representative of any health system because of the myriad of local factors that influence actual spending.PMID:38656319 | DOI:10.1093/ajhp/zxae105 (Source: American Journal of Health-System Pharmacy : AJHP)
Source: American Journal of Health-System Pharmacy : AJHP - April 24, 2024 Category: Drugs & Pharmacology Authors: Eric M Tichy James M Hoffman Mina Tadrous Matthew H Rim Sandra Cuellar John S Clark Mary Kate Newell Glen T Schumock Source Type: research

Projected prescription drug expenditures in 2024: Looking ahead to the inflation reduction era
Am J Health Syst Pharm. 2024 Apr 24:zxae104. doi: 10.1093/ajhp/zxae104. Online ahead of print.ABSTRACTIn an effort to expedite the publication of articles, AJHP is posting manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are posted online before technical formatting and author proofing. These manuscripts are not the final version of record and will be replaced with the final article (formatted per AJHP style and proofed by the authors) at a later time.PMID:38656543 | DOI:10.1093/ajhp/zxae104 (Source: American Journal of Health-System Pharmacy : AJHP)
Source: American Journal of Health-System Pharmacy : AJHP - April 24, 2024 Category: Drugs & Pharmacology Authors: Inmaculada Hernandez Source Type: research

The efficacy and safety of direct oral anticoagulants in the treatment of the acute phase of heparin-induced thrombocytopenia: A systematic review
CONCLUSION: Data from 12 publications and across 36 patients suggests that the use of DOACs in the acute phase of HIT may be a safe and efficacious treatment option with favorable ease of monitoring and management.PMID:38651828 | DOI:10.1093/ajhp/zxae109 (Source: American Journal of Health-System Pharmacy : AJHP)
Source: American Journal of Health-System Pharmacy : AJHP - April 23, 2024 Category: Drugs & Pharmacology Authors: Cooper Sadowski Justin P Reinert Source Type: research

Recommendations for pharmacogenetic testing in clinical practice guidelines in the US
CONCLUSION: A standardized approach to evaluating the evidence of clinical utility for pharmacogenetic testing may increase the inclusion and consistency of pharmacogenetic testing recommendations in clinical practice guidelines, which could benefit patients and society by increasing clinical use of pharmacogenetic testing.PMID:38652504 | DOI:10.1093/ajhp/zxae110 (Source: American Journal of Health-System Pharmacy : AJHP)
Source: American Journal of Health-System Pharmacy : AJHP - April 23, 2024 Category: Drugs & Pharmacology Authors: Daniel L Hertz Chad A Bousman Howard L McLeod Andrew A Monte Deepak Voora Lori A Orlando Rustin D Crutchley Benjamin Brown Wrenda Teeple Sara Rogers Jai N Patel Source Type: research

Correction to: Delayed-onset eptifibatide-induced thrombocytopenia
Am J Health Syst Pharm. 2024 Apr 16:zxae074. doi: 10.1093/ajhp/zxae074. Online ahead of print.NO ABSTRACTPMID:38624041 | DOI:10.1093/ajhp/zxae074 (Source: American Journal of Health-System Pharmacy : AJHP)
Source: American Journal of Health-System Pharmacy : AJHP - April 16, 2024 Category: Drugs & Pharmacology Source Type: research

Development and implementation of ambulatory care pharmacy services at an internal medicine clinic
CONCLUSION: By the fourth quarter of the first PGY2 residency year in which ambulatory care pharmacy services were provided in the clinic, the clinical and financial impact of those services justified the addition of a second full-time pharmacist to the clinic team.PMID:38613410 | DOI:10.1093/ajhp/zxae102 (Source: American Journal of Health-System Pharmacy : AJHP)
Source: American Journal of Health-System Pharmacy : AJHP - April 13, 2024 Category: Drugs & Pharmacology Authors: Casey Wells Anne Carrington Warren Mollie Ashe Scott Source Type: research

In memory of ASHP Past President Robert Lantos (1930-2021)
Am J Health Syst Pharm. 2024 Apr 9:zxae082. doi: 10.1093/ajhp/zxae082. Online ahead of print.NO ABSTRACTPMID:38591768 | DOI:10.1093/ajhp/zxae082 (Source: American Journal of Health-System Pharmacy : AJHP)
Source: American Journal of Health-System Pharmacy : AJHP - April 9, 2024 Category: Drugs & Pharmacology Authors: Kate Traynor Source Type: research

Commission on Goals tackles primary care delivery
Am J Health Syst Pharm. 2024 Apr 9:zxae092. doi: 10.1093/ajhp/zxae092. Online ahead of print.NO ABSTRACTPMID:38591769 | DOI:10.1093/ajhp/zxae092 (Source: American Journal of Health-System Pharmacy : AJHP)
Source: American Journal of Health-System Pharmacy : AJHP - April 9, 2024 Category: Drugs & Pharmacology Authors: Kate Traynor Source Type: research